Promising, new prognostic markers of esophageal carcinomas

APMIS

Volumn 121, Issue 10, 2013, Pages 1011-1011

  Kapoor, Shailendra ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR PITX2; TRANSCRIPTION FACTOR SOX3;

ATAXIA TELANGIECTASIA; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; ESOPHAGUS CARCINOMA; HUMAN; LETTER; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE;

CARCINOMA, SQUAMOUS CELL; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; MEMBRANE PROTEINS; SOXB1 TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84884721989     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12065     Document Type: Letter

References (5)

1. Wang J, Ma J, Dong Y, Shen Z, Ma H, Wang X, et al. High expression of EphA1 in esophageal squamous cell carcinoma is associated with lymph node metastasis and advanced disease.
2. Li K, Wang RW, Jiang YG, Zou YB, Guo W. Overexpression of Sox3 is Associated with Diminished Prognosis in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2012; in press.
3. Zhang JX, Tong ZT, Yang L, et al. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma. Int J Cancer 2012; in press.
4. Wang JH, Chen XT, Wen ZS, et al. High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosis. PLoS ONE. 2012; 7: e45622.
5. Lai W, Zhao J, Zhang C, et al. Upregulated ataxia-telangiectasia group D complementing gene correlates with poor prognosis in patients with esophageal squamous cell carcinoma. Dis Esophagus 2012; in press.